iX Biopharma Ltd. (SGX:42C)
Singapore · Delayed Price · Currency is SGD 0.1890
-0.0050 (-2.58%)
Jan 20, 2026, 5:15 PM SGT
iX Biopharma Market Cap
iX Biopharma has a market cap or net worth of 185.86 million as of January 20, 2026. Its market cap has increased by 709.26% in one year.
Market Cap
185.86M
Enterprise Value
190.83M
Revenue
7.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since July 22, 2015, iX Biopharma's market cap has decreased from 330.51M to 185.86M, a decrease of -43.76%. That is a compound annual growth rate of -5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 185.86M | 42.65% |
| Dec 31, 2025 | 130.29M | 490.01% |
| Dec 31, 2024 | 22.08M | -35.96% |
| Dec 28, 2023 | 34.48M | -65.12% |
| Dec 30, 2022 | 98.85M | -32.86% |
| Dec 31, 2021 | 147.23M | -17.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haw Par Corporation | 3.65B |
| Raffles Medical Group | 1.84B |
| Thomson Medical Group | 1.64B |
| Riverstone Holdings | 1.33B |
| Q & M Dental Group (Singapore) | 495.83M |
| Vicplas International | 47.02M |
| Cordlife Group | 39.22M |